Transcription of Benlysta, INN- belimumab
{{id}} {{{paragraph}}}
Example: dental hygienist
Benlysta, INN- belimumab
7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7455 E-mail Website An agency of the European Union assessment report Benlysta International Non proprietary Name: belimumab Procedure No. EMEA/H/C/002015 assessment Report as adopted by the CHMP with all information of a commercially confidential nature deleted Product information Name of the medicinal product: Benlysta Marketing Authorisation Holder: Glaxo Group Limited Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 0NN United Kingdom Active substance: belimumab International Non-proprietary Name: belimumab Pharmaco-therapeutic group (ATC Code): Selective immunosuppressants (L04AA26) Therapeutic indication.
7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7455 E-mail info@ema.europa.eu Website www.ema.europa.eu An agency of the European Union . Assessment report . Benlysta . International Non proprietary Name: belimumab . Procedure No. EMEA/H/C/002015 . Assessment …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: